Catabasis Pharmaceuticals Inc.

(CATB) Trade

By |

Profile

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker-drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of Duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis.

Contact Information

Website: www.catabasis.com
Email: amatthews@catabasis.com
Main Phone: +1 617 349-1971
Address: 100 High Street
Address 2: Floor 28
State: MA
City / Town: Boston
Country: US
Postal Code: 02110

Issuer Information

Exchange: NSD
CEO: Jill C. Milne
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker-drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of Duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis.

Contact Information

Website: www.catabasis.com
Email: amatthews@catabasis.com
Main Phone: +1 617 349-1971
Address: 100 High Street
Address 2: Floor 28
State: MA
City / Town: Boston
Country: US
Postal Code: 02110

Issuer Information

Exchange: NSD
CEO: Jill C. Milne
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 5.82 $ -0.08 (-1.36%)
Last Price 5.82 Change $ -0.08 Change % -1.36 Tick N/A
Bid 5.70 Bid Size 100.00 Ask 5.80 Ask Size 900.00
Open 5.99 High 6.02 Low 5.79 Prev Close 5.90
Last Trade Volume 148,966 52 Wk Hi 8.60 52 Wk Low 2.74
Market Cap 111.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 19,080,769.00 EPS (TTM) -2.14 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Nicholas G. Galakatos 1,000
Ron Laufer 1,000
Jean M. George 1,000
Jean M. George 1,000
Jean M. George 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 3.5 3.5 3.5 3.5
Mean Target Price Estimate 5.5 5.5 5.5 5.5
Standard Deviation 1.8 1.8 1.8 1.8
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1